6-K

DIRECTOR/PDMR SHAREHOLDING

Company: Indivior Pharmaceuticals, Inc.
Filed: March 4, 2024
Period of Report: March 4, 2024
Accession Number: 0001654954-24-002536

View Document ↗ View on SEC.gov ↗